One in four Vitality health insurance cancer claimants under 50

Breast cancer half of all claims from women

John Brazier
clock • 1 min read

The latest health insurance claims data from Vitality shows that one in four claimants was under 50 years old.

According to the insurer's data, breast cancer was the most common cancer claim from women of all ages, accounting for approximately half of all claims (49%) last year, followed by skin cancer (20%) and bowel cancer (6%).    Meanwhile, prostate cancer was the most prominent form of cancer in men over the age of 50 (33%), while skin cancer (31%) and bowel cancer (13%) were the most common form of cancer for men under 50. Vitality stated the types of cancer women claimed for in 2022 "does not change significantly as they age." The data includes all claims made over the past year, inc...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

Six in 10 adults would choose PMI as top employer-funded benefit
PMI

Six in 10 adults would choose PMI as top employer-funded benefit

27% have self-funded treatment over the past five years

Jaskeet Briah
clock 10 September 2025 • 3 min read
Perci Health appoints medical director to support expansion
PMI

Perci Health appoints medical director to support expansion

Launch of new specialist clinics

Jaskeet Briah
clock 04 September 2025 • 2 min read
Private healthcare admissions hit second highest level in Q1 2025
PMI

Private healthcare admissions hit second highest level in Q1 2025

Insured admissions remain stable

Jaskeet Briah
clock 02 September 2025 • 3 min read